Moreover, application of lanostane-type triterpene dehydrotrametenolic acid reduced hyperglycemia in mouse models of type 2 diabetes and acted as an insulin sensitizer (Figure 3) as indicated by the results of the glucose tolerance test, which makes it a promising candidate for a new type of insulin-sensitizing drug [91]. The gene discussed is INS; the disease is type 2 diabetes mellitus.